French Cell Chip Maker Cytoo Raises $4.7M, Opens US Shop

According to President and co-CEO Francois Chatelain, Cytoo is ready to make a move on the North American market to grow sales, attract customers, streamline logistics, and position itself for further rounds of financing.

Biolog Nets $923K ARRA Grant to Upgrade Cell Array Platform

CEO Barry Bochner said that Biolog will use the funds to continue adapting its Phenotype Microarray platform to study Mycobacterium tuberculosis and other fastidious pathogens, expand its Microbial Identification System to cover more fastidious species, and work with researchers at Texas A&M University to study gene function in Mycobacterium.

CSIRO-Led Team Adopts Biolog's Cell-Array Platform for Wheat Toxin Study

Appearing in the online editions of Fungal Genetics and Biology and Microbiology, the papers describe the use of Biolog's Phenotype Microarray platform to research secondary pathways in F. graminearum, which is responsible for head blight and crop losses.

Roche Buys Innovatis for $20.5M in Bid to Boost Bioproduction, Cell Fermentation QC Play

Innovatis' cell counting, cell viability testing, and cell acquisition measurement technology is compatible with Roche's xCELLigence platform, according to a Roche Applied Science official.

EPA Presents Phase I ToxCast Data for First Time, Extends Acea's Participation for One Year

In addition, the EPA and Acea have been collaborating on the publication of paper that will report Acea's ToxCast data. The paper has been submitted and the partners "should hear back fairly soon" about when and in what journal it will appear.

Nexcelom's New Hepatocyte App for Cellometer Vision Provides Automated Counting Method

According to a company official, this application provides an automated counting method for a type of cell for which one does not currently exist.

Patent Watch

Cyntellect and the University of Michigan Awarded US Patents

News Scan

Thermo Fisher Scientific, North Carolina Biotechnology Center, Life Technologies, Cenix BioScience, AstraZeneca, MultiCell Technologies, Maxim Biotech, CyBio, Axxam, PerkinElmer, Sangmyung University

New Products

Thermo Fisher Scientific

End of Federal hESC Restrictions Will Enable Use of PGD Lines, Remove Stigma

Lifting the ban, which "lift[s] the cloud of scrutiny of stem cells," could also increase federal funding of hESC lines, which could increase discoveries of new assay systems, cellular-differentiation pathways, and small molecules.

From Genome Technology

The Search for New Drugs

Drug discovery no longer belongs solely in the hands of drug companies. Pharmas are partnering with nonprofit and other groups, while academia is striking out on its own.